Bernd Schmidt is the Chief Technical Officer of Sensorion, where he leads the CMC development of breakthrough therapies for inner ear disorders.

With over two decades of experience in bringing innovative medicines from the lab to patients, he has worked across small biotech and large pharma, including senior leadership roles at Quell Therapeutics, GSK and AstraZeneca. His career has spanned the development and launch of new medicines across modalities, incl. cutting-edge gene and CAR-T cell therapies, to overseeing complex global supply chains.

Bernd is driven by a passion for improving patients’ lives and a belief that high-performing, collaborative teams are the key to turning scientific innovation into real-world impact.